Aceragen Inc
ACGN
ACGN was delisted on the 21st of August, 2023.
3 hedge funds and large institutions have $22 invested in Aceragen Inc in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 17 closing their positions.
85% less funds holding
Funds holding: 20 → 3 (-17)
100% less capital invested
Capital invested by funds: $270K → $22 (-$270K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 17
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$121K |
| 2 |
BlackRock
New York
|
-$41.1K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$38K |
| 4 |
State Street
Boston,
Massachusetts
|
-$19K |
| 5 |
Credit Agricole
Montrouge Cedex,
France
|
-$18.8K |
ACGN Hedge Fund Activity: Q3 2023 in Review
3 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Aceragen Inc (ACGN) for Q3 2023, worth a combined $22 — down 100% from $270K a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of ACGN and 0 opened new positions — a net loss of 17 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Vanguard Group, exiting entirely with an estimated $121K sold.
- 3 institutional investors held Aceragen Inc (ACGN) as of Q3 2023, down from 20 in Q2 2023.
- Funds reported $22 of Aceragen Inc stock for Q3 2023, down 100% quarter-over-quarter.
- 0 funds opened new Aceragen Inc positions in Q3 2023 and 17 closed out, a net change of -17 holders.
- The largest Aceragen Inc seller in Q3 2023 was Vanguard Group, an estimated $121K sold.
Based on aggregated 13F filings for Q3 2023.